Natixis Advisors LLC increased its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 19.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 521,251 shares of the company’s stock after purchasing an additional 85,590 shares during the period. Natixis Advisors LLC’s holdings in Cardinal Health were worth $107,117,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Versor Investments LP bought a new position in Cardinal Health in the 3rd quarter worth approximately $2,090,000. Machina Capital S.A.S. raised its position in shares of Cardinal Health by 248.0% during the 3rd quarter. Machina Capital S.A.S. now owns 27,054 shares of the company’s stock valued at $4,246,000 after acquiring an additional 19,280 shares during the last quarter. Nordea Investment Management AB raised its position in shares of Cardinal Health by 328.3% during the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock valued at $133,741,000 after acquiring an additional 494,731 shares during the last quarter. Candriam S.C.A. raised its position in shares of Cardinal Health by 10.8% during the 3rd quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock valued at $30,790,000 after acquiring an additional 19,155 shares during the last quarter. Finally, Victory Capital Management Inc. raised its position in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock valued at $352,165,000 after acquiring an additional 707,495 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have commented on CAH. Mizuho upped their target price on shares of Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a research report on Friday, February 6th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Citigroup dropped their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research report on Friday, May 1st. William Blair began coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating for the company. Finally, JPMorgan Chase & Co. dropped their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $241.80.
Cardinal Health Trading Down 0.1%
Shares of NYSE CAH opened at $194.96 on Wednesday. The firm has a market cap of $45.66 billion, a PE ratio of 29.81, a PEG ratio of 1.16 and a beta of 0.52. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The company has a fifty day moving average price of $203.21 and a 200 day moving average price of $208.75.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the prior year, the business earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
